Beijing, China · Founded 2019 · Privately Held (backing)
Developer of surgical implant products containing human extracellular matrix and collagen designed for medical beauty. MayBio Biomedical is based in Beijing, China and was founded in 2019. Its last reported valuation was $11.4 million in Aug 2020. It has raised $2.9 million.
Last reported valuation
$11.4M
Oct 2026
Priced at
—
Total raised
$2.9M
Last round
—
Cap table — not yet on record
MayBio Biomedical's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MayBio Biomedical with a free account
·Watch MayBio Biomedical: the Monday email on marks, rounds and moves
